Intuitive Surgical, Inc. Stock Before Open (19 Dec 2025): AI Innovations Boost Expectations
With growing demand for AI-driven solutions in healthcare, Intuitive Surgical, Inc. (NASDAQ: ISRG) is positioned for potential growth. As pre-market trading continues, investors eye AI advancements bolstering Intuitive Surgical’s capabilities, especially their renowned da Vinci Surgical System.
Intuitive Surgical’s AI Integration
Intuitive Surgical has been at the forefront of integrating artificial intelligence into medical technology. The company’s da Vinci Surgical System stands out as a leading solution that uses AI for enhanced precision in minimally invasive surgeries. This integration not only improves surgical outcomes but also drives operational efficiencies for healthcare providers, fueling growth in its market share.
Recent Performance and Market Metrics
As of December 19, 2025, ISRG is trading at USD 561.89, up 0.90% from the previous day. The stock reached a year low of USD 425.00 and a high of USD 616.00. Its 50-day and 200-day moving averages are USD 533.74 and USD 507.91, respectively. Despite the lower-than-average trading volume of 1,518,446 shares, investor sentiment remains positive due in part to recent earnings surpassing estimates.
Earnings and Financial Growth
Intuitive Surgical reported an EPS of 2.19 versus an estimated 1.93 in the last quarter, with revenues of USD 2.44 billion, surpassing expectations. The company’s net income per share TTM is USD 7.70, and it boasts a strong balance sheet with zero debt to equity, reflecting robust financial health. The revenue and gross profit growth rates were 17.24% and 19.13%, respectively, indicating significant annual progress.
AI-Driven Forecasts and Analyst Ratings
Meyka AI rates ISRG with a score of 80.64 (Grade A), suggesting a ‘BUY’ recommendation. The Meyka AI forecast projects ISRG’s three-year price target at USD 647.25, reflecting a potential upside of 15.16% from the current price. Analysts have a consensus price target of USD 602.76, indicating continued confidence in ISRG’s trajectory fueled by its AI advancements. These grades and forecasts are based on AI models that factor in sector and industry performance, key financial metrics, and historical data.
Final Thoughts
Intuitive Surgical, Inc.’s strategic integration of AI into its surgical systems positions it well for future growth. With a solid financial foundation and positive market sentiment, ISRG presents a compelling case for investors looking to leverage AI’s impact on healthcare. However, as always, stock prices are subject to fluctuations based on market conditions.
FAQs
As of December 19, 2025, Intuitive Surgical’s stock price is USD 561.89 per share on NASDAQ. This represents a 0.90% increase from the previous close.
Intuitive Surgical integrates AI for improved precision in surgeries, enhancing the effectiveness of its da Vinci Surgical System. This leads to better outcomes and efficiencies for healthcare providers.
For the last reported quarter, Intuitive Surgical posted an EPS of 2.19 against an estimated 1.93 and achieved revenues of USD 2.44 billion, exceeding forecasts.
Meyka AI rates ISRG with a score of 80.64, giving it a Grade A and a ‘BUY’ recommendation based on its AI-powered assessment of various financial and market factors.
As with any stock, investing in ISRG carries risks linked to market volatility, economic conditions, and company-specific developments. Investors should conduct thorough research before making investment decisions.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
